Acute and intermediate‐term procedural results using cypher stenting to treat multi‐vessel coronary artery disease

R. Kornowski,H. Vaknin-Assa,A. Assali,S. Fuchs
DOI: https://doi.org/10.1080/14628840500306875
2005-07-01
International Journal of Cardiovascular Interventions
Abstract:OBJECTIVE: We examined our experience using the sirolimus eluting stents (Cypher) as an alternative to surgical revascularization in carefully selected cohort of patients undergoing multi‐vessel percutaneous coronary intervention. METHODS: Fifty consecutive patients with multi‐vessel disease who were good candidates for both surgical and percutaneous revascularization were included in the current analysis. All patients underwent a careful clinical evaluation prior to the intervention, and they were followed for procedural and clinical outcomes for nine months. RESULTS: Mean age was 64±11 years (40 males, 30% diabetics) and 10 patients (20%) had three‐vessel disease. Angina class was 2.7±0.6 at baseline. Overall, 116 lesions were treated using 122 stents (mean 2.4 stents per patient). Total mean stent length was 43±12 mm (range: 21–90 mm). Overall, one patient died during follow‐up (2%), no patient had stroke or Q wave MI and one patient experienced non‐Q myocardial infarction. There was no documented stent thrombosis and two patients (4%) underwent target‐vessel revascularization. The hierarchical cumulative major adverse cardiac event rate was 8% and the cardiac event‐free survival rate was thus 92%. CONCLUSION: Multi‐vessel stenting using Cypher stents is a viable treatment strategy in selected group of patients with multi‐vessel coronary artery disease. It is associated with excellent intermediate‐term clinical outcomes and thus it could serve as the primary revascularization strategy of choice in appropriate candidates.
What problem does this paper attempt to address?